Satureja khuzestanica attenuates apoptosis in hyperglycemic PC12 cells and spinal cord of diabetic rats

Journal of Natural Medicines

Volumn 67, Issue 1, 2013, Pages 61-69

  Kaeidi, Ayat ^a,b,c   Esmaeili Mahani, Saeed ^b   Abbasnejad, Mehdi ^b   Sheibani, Vahid ^a   Rasoulian, Bahram ^c   Hajializadeh, Zahra ^b   Pasban Aliabadi, Hamzeh ^b  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BAHONAR UNIVERSITY OF KERMAN   (Iran)

^c LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Diabetic neuropathy; Hyperalgesia; PC12 cells; Rats; Satureja khuzestanica

Indexed keywords

CASPASE 3; GLUCOSE; INSULIN; PLANT EXTRACT; PROTEIN BAX; PROTEIN BCL 2; SATUREJA KHUZESTANICA EXTRACT; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BODY WEIGHT; CELL DAMAGE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENZYME ACTIVATION; ENZYME INHIBITION; GLUCOSE BLOOD LEVEL; HYPERALGESIA; HYPERGLYCEMIA; IMMUNOBLOTTING; IN VITRO STUDY; IN VIVO STUDY; MEDICINAL PLANT; MOTOR COORDINATION; NEUROPROTECTION; NOCICEPTION; NONHUMAN; PHEOCHROMOCYTOMA CELL; PROTEIN CLEAVAGE; RAT; ROTAROD TEST; SATUREJA KHUZESTANICA; SPINAL CORD; STREPTOZOCIN DIABETES; TAIL FLICK TEST; TREADMILL; UPREGULATION; WESTERN BLOTTING;

ANIMALS; APOPTOSIS; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DNA FRAGMENTATION; IMMUNOBLOTTING; MALE; PC12 CELLS; PLANT EXTRACTS; RATS; RATS, WISTAR; SATUREJA;

EID: 84871287593     PISSN: 13403443     EISSN: 18610293     Source Type: Journal    
DOI: 10.1007/s11418-012-0646-y     Document Type: Article

References (37)

1. Dyck PJ, Albers JW, Andersen H, Arezzo JC, Biessels GJ, Bril V, Feldman EL, Litchy WJ, O'Brien PC, Russell JW (on behalf of the Toronto Expert Panel on Diabetic Neuropathy) (2011) Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes Metab Res Rev. doi: 10.1002/dmrr.1226
2. Tomlinson DR, Gardiner NJ (2008) Glucose neurotoxicity. Nat Rev Neurosci 9:36-45 (Pubitemid 350295687)
3. Edwards JL, Vincent AM, Cheng HT, Feldman EL (2008) Diabetic neuropathy: mechanisms to management. Pharmacol Ther 120:1-34
4. Kamboj SS, Vasishta RK, Sandhir R (2010) N-acetylcysteine inhibits hyperglycemia-induced oxidative stress and apoptosis markers in diabetic neuropathy. J Neurochem 112:77-91
5. Lelkes E, Unsworth BR, Lelkes PI (2001) Reactive oxygen species, apoptosis and altered NGF-induced signaling in PC12 pheochromocytoma cells cultured in elevated glucose: An in vitro cellular model for diabetic neuropathy. Neurotox Res 3:189-203 (Pubitemid 32936866)
6. Russell JW, Golovoy D, Vincent AM, Mahendru P, Olzmann JA, Mentzer A, Feldman EL (2002) High glucose-induced oxidative stress and mitochondrial dysfunction in neurons. FASEB J 16:1738-1748 (Pubitemid 35340354)
7. Ji HF, Zhang HY (2008) Multipotent natural agents to combat Alzheimer's disease. Functional spectrum and structural features. Acta Pharmacol Sin 29:143-151 (Pubitemid 351178433)
8. Bei W, Zang L, Guo J, Peng W, Xu A, Good DA, Hu Y, Wu W, Hu D, Zhu X, Wei M, Li G (2009) Neuroprotective effects of a standardized flavonoid extract from Diospyros kaki leaves. J Ethnopharmacol 126:134-142
9. Kaeidi A, Esmaeili-Mahani S, Sheibani V, Abbasnejad M, Rasoulian B, Hajializadeh Z, Afrazi S (2011) Olive (Olea europaea L.) leaf extract attenuates early diabetic neuropathic pain through prevention of high glucose-induced apoptosis: in vitro and in vivo studies. J Ethnopharmacol 136:188-196
10. Zargari A (1990) Medicinal plants. Tehran University Publications, Tehran, pp 42-45
11. Momtaz S, Abdollahi M (2010) An update on pharmacology of satureja species; from antioxidant, antimicrobial, antidiabetes and anti-hyperlipidemic to reproductive stimulation. Int J Pharmacol 6:346-353
12. Vosough-Ghanbari S, Rahimi R, Kharabaf S, Zeinali S, Mohammadirad A, Amini S, Yasa N, Salehnia A, Toliat T, Nikfar S, Larijani B, Abdollahi M (2010) Effects of Satureja khuzestanica on serum glucose, lipids and markers of oxidative stress in patients with type 2 diabetes mellitus: A double-blind randomized controlled trial. Evid Based Complement Alternat Med 7:465-470
13. Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271-277 (Pubitemid 16080782)
14. Zimmermann M (1983) Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16:109-110 (Pubitemid 13058546)
15. Hajializadeh Z, Esmaeili-Mahani S, Sheibani V, Kaeidi A, Atapour M, Abbasnejad M (2010) Changes in the gene expression of specific G-protein subunits correlate with morphine insensitivity in streptozotocin-induced diabetic rats. Neuropeptides 44:299-304
16. D'Amour FE, Smith DL (1941) A method of determining loss of pain sensation. J Pharmacol Exp Ther 27:74-79
17. 2+ channels in rats. J Neurosci Res 86:471-479 (Pubitemid 351196753)
18. Cartmell SM, Gelgor L, Mitchell D (1991) A revised rota-rod procedure for measuring the effect of antinociceptive drugs on motor function in the rat. J Pharmacol Methods 26:149-159
19. Vincent AM, Mclean LL, Backus C, Feldman LL (2005) Short-term hyperglycemia produces oxidative damage and apoptosis in neurons. FASEB J 19:638-640 (Pubitemid 40471270)
20. Vincent AM, Callaghan BC, Smith AL, Feldman EL (2011) Diabetic neuropathy: cellular mechanisms as therapeutic targets. Nat Rev Neurol 13:573-583
21. Pazdro R, Burgess JR (2010) The role of vitamin E and oxidative stress in diabetes complications. Mech Ageing Dev 131:276-286
22. Guimarães AG, Oliveira GF, Melo MS, Cavalcanti SC, Antoniolli AR, Bonjardim LR, Silva FA, Santos JP, Rocha RF, Moreira JC, Araújo AA, Gelain DP, Quintans-Júnior LJ (2010) Bioassay-guided evaluation of antioxidant and antinociceptive activities of carvacrol. Basic Clin Pharmacol Toxicol 107:949-957
23. Abdollahi M, Salehnia A, Mortazavi SH, Ebrahimi M, Shafiee A, Fouladian F, Keshavarz K, Sorouri S, Khorasani R, Kazemi A (2003) Antioxidant, antidiabetic, antihyperlipidemic, reproduction stimulatory properties and safety of essential oil of Satureja khuzestanica in rat in vivo: A oxicopharmacological study. Med Sci Monit 9:BR331-5 (Pubitemid 37295228)
24. Orrenius S, Gogvadze V, Zhivotovsky B (2007) Mitochondrial oxidative stress: implications for cell death. Annu Rev Pharmacol Toxicol 47:143-183
25. Circu ML, Aw TY (2010) Reactive oxygen species, cellular redox systems, and apoptosis. Free Radic Biol Med 48:749-762
26. Sharifi AM, Eslami H, Larijani B, Davoodi J (2009) Involvement of caspase-8, -9, and -3 in high glucose-induced apoptosis in PC12 cells. Neurosci Lett 459:47-51
27. Joseph EK, Levine JD (2004) Caspase signalling in neuropathic and inflammatory pain in the rat. Eur J Neurosci 20:2896-2902 (Pubitemid 40007283)
28. Sekiguchi M, Sekiguchi Y, Konno S, Kobayashi H, Homma Y, Kikuchi S (2009) Comparison of neuropathic pain and neuronal apoptosis following nerve root or spinal nerve compression. Eur Spine J 18:1978-1985
29. Amanlou M, Dadkhah F, Salehnia A, Farsam H, Dehpour AR (2005) An anti-inflammatory and anti-nociceptive effects of hydroalcoholic extract of Satureja khuzestanica Jamzad extract. J Pharm Pharm Sci 8:102-106 (Pubitemid 41528875)
30. Kumar A, Negi G, Sharma SS (2011) JSH-23 targets nuclear factor-kappa B and reverses various deficits in experimental diabetic neuropathy: effect on neuroinflammation and antioxidant defence. Diabetes Obes Metab 13:750-758
31. Negi G, Kumar A, Sharma SS (2011) Melatonin modulates neuroinflammation and oxidative stress in experimental diabetic neuropathy: effects on NF-κB and Nrf2 cascades. J Pineal Res 50:124-131
32. Chopra K, Tiwari V, Arora V, Kuhad A (2010) Sesamol suppresses neuro-inflammatory cascade in experimental model of diabetic neuropathy. J Pain 11:950-957
33. Guimarães AG, Xavier MA, de Santana MT, Camargo EA, Santos CA, Brito FA, Barreto EO, Cavalcanti SC, Antoniolli AR, Oliveira RC, Quintans-Júnior LJ (2012) Carvacrol attenuates mechanical hypernociception and inflammatory response. Naunyn Schmiedebergs Arch Pharmacol PMID:22139435
34. Hotta M, Nakata R, Katsukawa M, Hori K, Takahashi S, Inoue H (2010) Carvacrol, a component of thyme oil, activates PPAR alpha and gamma, and suppresses COX-2 expression. J Lipid Res 51:132-139
35. Adriaensen H, Plaghki L, Mathieu C, Joffroy A, Vissers K (2005) Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies. Diabetes Metab Res Rev 21:231-240 (Pubitemid 40716154)
36. Tesfaye S, Tandan R, Bastyr EJ 3rd, Kles KA, Skljarevski V, Price KL (2007) Factors that impact symptomatic diabetic peripheral neuropathy in placebo-administered patients from two 1-year clinical trials. Diabetes Care 30:2626-2632 (Pubitemid 47547808)
37. Shahsavari R, Ehsani-Zonouz A, Houshmand M, Salehnia A, Ahangari G, Firoozrai M (2009) Plasma glucose lowering effect of the wild Satureja khuzestanica Jamzad essential oil in diabetic rats: role of decreased gluconeogenesis. Pak J Biol Sci 12:140-145